{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T03:27:53Z","timestamp":1776310073977,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12325-020-01255-8","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T02:02:57Z","timestamp":1583892177000},"page":"1608-1619","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Evaluation of Nurse Preferences Between the Lanreotide Autogel New Syringe and the Octreotide Long-Acting Release Syringe: An International Simulated-Use Study (PRESTO)"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9021-076X","authenticated-orcid":false,"given":"Daphne","family":"Adelman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan-Mai","family":"Truong Thanh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Feuilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aude","family":"Houchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Cella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,11]]},"reference":[{"key":"1255_CR1","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJMoa1316158","volume":"371","author":"ME Caplin","year":"2014","unstructured":"Caplin ME, Pavel M, Cwikla JB, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med. 2014;371:224\u201333.","journal-title":"N Engl J Med"},{"key":"1255_CR2","doi-asserted-by":"publisher","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","volume":"27","author":"A Rinke","year":"2009","unstructured":"Rinke A, Muller HH, Schade-Brittinger C, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol. 2009;27:4656\u201363.","journal-title":"J Clin Oncol"},{"key":"1255_CR3","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3748\/wjg.v16.i24.2963","volume":"16","author":"J Strosberg","year":"2010","unstructured":"Strosberg J, Kvols L. Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors. World J Gastroenterol. 2010;16:2963\u201370.","journal-title":"World J Gastroenterol"},{"key":"1255_CR4","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1210\/jc.2013-3318","volume":"99","author":"PJ Caron","year":"2014","unstructured":"Caron PJ, Bevan JS, Petersenn S, et al. Tumor shrinkage with lanreotide Autogel 120\u00a0mg as primary therapy in acromegaly: results of a prospective multicenter clinical trial. J Clin Endocrinol Metab. 2014;99:1282\u201390.","journal-title":"J Clin Endocrinol Metab"},{"key":"1255_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1365-2036.2011.04693.x","volume":"34","author":"MS Khan","year":"2011","unstructured":"Khan MS, El-Khouly F, Davies P, Toumpanakis C, Caplin ME. Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel). Aliment Pharmacol Ther. 2011;34:235\u201342.","journal-title":"Aliment Pharmacol Ther"},{"key":"1255_CR6","doi-asserted-by":"publisher","first-page":"R551","DOI":"10.1530\/ERC-16-0151","volume":"23","author":"K Oberg","year":"2016","unstructured":"Oberg K, Lamberts SW. Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future. Endocr Relat Cancer. 2016;23:R551\u201366.","journal-title":"Endocr Relat Cancer"},{"key":"1255_CR7","first-page":"103","volume":"5","author":"DT Adelman","year":"2012","unstructured":"Adelman DT, Burgess A, Davies PR. Evaluation of long-acting somatostatin analog injection devices by nurses: a quantitative study. Med Dev (Auckl). 2012;5:103\u20139.","journal-title":"Med Dev (Auckl)."},{"key":"1255_CR8","doi-asserted-by":"publisher","first-page":"E139","DOI":"10.1188\/16.CJON.E139-E146","volume":"20","author":"P Ryan","year":"2016","unstructured":"Ryan P, Phan AT, Adelman DT, Iwasaki M. Neuroendocrine tumors and lanreotide depot: clinical considerations and nurse and patient preferences. Clin J Oncol Nurs. 2016;20:E139\u201346.","journal-title":"Clin J Oncol Nurs."},{"key":"1255_CR9","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1007\/s12325-019-01112-3","volume":"36","author":"DT Adelman","year":"2019","unstructured":"Adelman DT, Van Genechten D, Megret CM, Truong Thanh XMT, Hand P, Martin WA. Co-creation of a lanreotide autogel\/depot syringe for the treatment of acromegaly and neuroendocrine tumours through collaborative human factor studies. Adv Ther. 2019;36:3409\u201323.","journal-title":"Adv Ther."},{"key":"1255_CR10","unstructured":"Novartis. Sandostatin\u00ae LAR summary of product characteristics. 2018. https:\/\/www.medicines.org.uk\/emc\/product\/1038\/smpc. Accessed 22 Nov 2019."},{"key":"1255_CR11","unstructured":"Ipsen Ltd. Somatuline\u00ae Autogel\u00ae summary of product characteristics. 2019. https:\/\/www.medicines.org.uk\/emc\/product\/8257\/smpc. Accessed 22 Nov 2019."},{"key":"1255_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/2374373517714453","volume":"4","author":"JG Chen","year":"2017","unstructured":"Chen JG, Zou B, Shuster J. Relationship between patient satisfaction and physician characteristics. J Patient Exp. 2017;4:177\u201384.","journal-title":"J Patient Exp"},{"key":"1255_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.35680\/2372-0247.1357","volume":"6","author":"E Godden","year":"2019","unstructured":"Godden E, Paseka A, Gnida J, Inguanzo J. The impact of response rate on Hospital Consumer Assessment of Healthcare Providers and System (HCAHPS) dimension scores. Patient Exp J. 2019;6:105\u201314.","journal-title":"Patient Exp J"},{"key":"1255_CR14","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/jhm.2533","volume":"11","author":"K Indovina","year":"2016","unstructured":"Indovina K, Keniston A, Reid M, et al. Real-time patient experience surveys of hospitalized medical patients. J Hosp Med. 2016;11:251\u20136.","journal-title":"J Hosp Med."},{"key":"1255_CR15","unstructured":"Reichheld F. The one number you need to grow: Harvard business review; 2003. https:\/\/hbr.org\/2003\/12\/the-one-number-you-need-to-grow#. Accessed 9 Jan 2019."},{"key":"1255_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11102-009-0207-x","volume":"13","author":"R Salvatori","year":"2010","unstructured":"Salvatori R, Nachtigall LB, Cook DM, et al. Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naive patients with acromegaly. Pituitary. 2010;13:115\u201322.","journal-title":"Pituitary."},{"key":"1255_CR17","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1177\/1078155219839458","volume":"25","author":"P Ryan","year":"2019","unstructured":"Ryan P, McBride A, Ray D, et al. Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: an observational time and motion analysis. J Oncol Pharm Pract. 2019;25:1425\u201333.","journal-title":"J Oncol Pharm Pract."},{"key":"1255_CR18","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.2147\/PPA.S213472","volume":"13","author":"T Str\u00f6m","year":"2019","unstructured":"Str\u00f6m T, Kozlovacki G, Myrenfors P, Almquist M. Patient and nurse experience of using somatostatin analogues to treat gastroeneteropancreatic neuroendocrine tumors: results of the Somatostatin Treatment Experience Trial (STREET). Patient Prefer Adher. 2019;13:1799\u2013807.","journal-title":"Patient Prefer Adher."},{"key":"1255_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1530\/eje.0.1510317","volume":"151","author":"O Alexopoulou","year":"2004","unstructured":"Alexopoulou O, Abrams P, Verhelst J, et al. Efficacy and tolerability of lanreotide Autogel therapy in acromegalic patients previously treated with octreotide LAR. Eur J Endocrinol. 2004;151:317\u201324.","journal-title":"Eur J Endocrinol"},{"key":"1255_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s40744-017-0080-4","volume":"4","author":"M Schiff","year":"2017","unstructured":"Schiff M, Saunderson S, Mountian I, Hartley P. Chronic disease and self-injection: ethnographic investigations into the patient experience during treatment. Rheumatol Ther. 2017;4:445\u201363.","journal-title":"Rheumatol Ther."},{"key":"1255_CR21","doi-asserted-by":"crossref","unstructured":"Matza LS, Stewart KD, Paczkowski R, Coyne KS, Currie B, Boye KSJJoP-RO. Psychometric evaluation of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ). 2018;2:44.","DOI":"10.1186\/s41687-018-0064-3"},{"key":"1255_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s13300-017-0237-8","volume":"8","author":"L Qin","year":"2017","unstructured":"Qin L, Chen S, Flood E, et al. Glucagon-like peptide-1 receptor agonist treatment attributes important to injection-experienced patients with type 2 diabetes mellitus: a preference study in Germany and the United Kingdom. Diabetes Ther. 2017;8:335\u201353.","journal-title":"Diabetes Ther."},{"key":"1255_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.gerinurse.2017.11.007","volume":"39","author":"N Pandya","year":"2018","unstructured":"Pandya N, Losben N, Moore J. Optimizing insulin delivery for patients with diabetes. Geriatr Nurs. 2018;39:138\u201342.","journal-title":"Geriatr Nurs"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01255-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-020-01255-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01255-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T14:48:12Z","timestamp":1712242092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-020-01255-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,11]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1255"],"URL":"https:\/\/doi.org\/10.1007\/s12325-020-01255-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,11]]},"assertion":[{"value":"22 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}